IRS posttranslational modifications in regulating insulin signaling

Jinghua Peng, Ling He

Research output: Contribution to journalReview articlepeer-review


Insulin resistance is the hallmark of type 2 diabetes; however, the mechanism underlying the development of insulin resistance is still not completely understood. Previous reports showed that posttranslational modifications of IRS play a critical role in insulin signaling, especially the phosphorylation of IRS by distinct kinases. While it is known that increasing Sirtuin1 deacetylase activity improves insulin sensitivity in the liver, the identity of its counterpart, an acetyl-transferase, remains unknown. Our recent study shows that elevated endotoxin (LPS) levels in the liver of obese mice lead to the induction of the acetyl-transferase P300 through the IRE1-XBP1s pathway. Subsequently, induced P300 impairs insulin signaling by acetylating IRS1 and IRS2 in the insulin signaling pathway. Therefore, the P300 acetyl-transferase activity appears to be a promising therapeutic target for the treatment of diabetes.

Original languageEnglish (US)
Pages (from-to)R1-R8
JournalJournal of Molecular Endocrinology
Issue number1
StatePublished - Jan 2018


  • Diabetes II
  • Insulin action
  • Insulin receptor
  • Insulin signaling
  • Liver

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology


Dive into the research topics of 'IRS posttranslational modifications in regulating insulin signaling'. Together they form a unique fingerprint.

Cite this